Seroba Life Sciences

Seroba is a leading European life sciences venture capital firm, dedicated to creating value by supporting innovative biotech and medtech companies. With a focus on breakthrough technologies, Seroba has backed significant advancements such as Shorla Oncology's FDA-approved TEPYLUTE, a ready-to-dilute formulation for treating breast and ovarian cancer. Based in Dublin, Seroba leverages deep industry expertise to help entrepreneurs build world-class businesses, fostering extraordinary scientific innovations.